# Intravenous Lidocaine for Cystectomy Procedures

> **NCT02924480** · NA · COMPLETED · sponsor: **CAMC Health System** · enrollment: 50 (actual)

## Conditions studied

- Invasive Bladder Cancer

## Interventions

- **PROCEDURE:** Cystectomy
- **DRUG:** Lidocaine
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT02924480
- **Lead sponsor:** CAMC Health System
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-12
- **Primary completion:** 2020-06-17
- **Final completion:** 2020-06-17
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02924480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02924480, "Intravenous Lidocaine for Cystectomy Procedures". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02924480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*